Literature DB >> 21088470

Microglial P2X₇ receptor expression is accompanied by neuronal damage in the cerebral cortex of the APPswe/PS1dE9 mouse model of Alzheimer's disease.

Hwan Goo Lee1, Sun Mi Won, Byoung Joo Gwag, Yong Beom Lee.   

Abstract

The possibility that P2X₇ receptor (P2X₇R) expression in microglia would mediate neuronal damage via reactive oxygen species (ROS) production was examined in the APPswe/PS1dE9 mouse model of Alzheimer's disease (AD). P2X7R was predominantly expressed in CD11b-immunopositive microglia from 3 months of age before Abeta plaque formation. In addition, gp91phox, a catalytic subunit of NADPH oxidase, and ethidium fluorescence were detected in P2X₇R-positive microglial cells of animals at 6 months of age, indicating that P2X₇R-positive microglia could produce ROS. Postsynaptic density 95-positive dendrites showed significant damage in regions positive for P2X₇R in the cerebral cortex of 6 month-old mice. Taken together, up-regulation of P2X₇R activation and ROS production in microglia are parallel with Aβ increase and correlate with synaptotoxicity in AD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21088470      PMCID: PMC3041940          DOI: 10.3858/emm.2011.43.1.001

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  47 in total

1.  Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques.

Authors:  Robert M Koffie; Melanie Meyer-Luehmann; Tadafumi Hashimoto; Kenneth W Adams; Matthew L Mielke; Monica Garcia-Alloza; Kristina D Micheva; Stephen J Smith; M Leo Kim; Virginia M Lee; Bradley T Hyman; Tara L Spires-Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-19       Impact factor: 11.205

2.  Activation of microglia by amyloid {beta} requires P2X7 receptor expression.

Authors:  Juana M Sanz; Paola Chiozzi; Davide Ferrari; Marilena Colaianna; Marco Idzko; Simonetta Falzoni; Renato Fellin; Luigia Trabace; Francesco Di Virgilio
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

3.  Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis.

Authors:  Diego Centonze; Luca Muzio; Silvia Rossi; Francesca Cavasinni; Valentina De Chiara; Alessandra Bergami; Alessandra Musella; Marcello D'Amelio; Virve Cavallucci; Alessandro Martorana; Andrea Bergamaschi; Maria Teresa Cencioni; Adamo Diamantini; Erica Butti; Giancarlo Comi; Giorgio Bernardi; Francesco Cecconi; Luca Battistini; Roberto Furlan; Gianvito Martino
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

4.  Inflammatory response in the hippocampus of PS1M146L/APP751SL mouse model of Alzheimer's disease: age-dependent switch in the microglial phenotype from alternative to classic.

Authors:  Sebastian Jimenez; David Baglietto-Vargas; Cristina Caballero; Ines Moreno-Gonzalez; Manuel Torres; Raquel Sanchez-Varo; Diego Ruano; Marisa Vizuete; Antonia Gutierrez; Javier Vitorica
Journal:  J Neurosci       Date:  2008-11-05       Impact factor: 6.167

5.  ATP released from beta-amyloid-stimulated microglia induces reactive oxygen species production in an autocrine fashion.

Authors:  Soo Yoon Kim; Ju Hyun Moon; Hwan Goo Lee; Seung Up Kim; Yong Beom Lee
Journal:  Exp Mol Med       Date:  2007-12-31       Impact factor: 8.718

6.  Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age.

Authors:  Hafiz Mohmmad Abdul; Rukhsana Sultana; Daret K St Clair; William R Markesbery; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2008-08-16       Impact factor: 7.376

Review 7.  Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models.

Authors:  Joshua A Sonnen; John C Breitner; Mark A Lovell; William R Markesbery; Joseph F Quinn; Thomas J Montine
Journal:  Free Radic Biol Med       Date:  2008-04-24       Impact factor: 7.376

Review 8.  An update on the amyloid hypothesis.

Authors:  Christopher B Eckman; Elizabeth A Eckman
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

9.  Microglial activation and amyloid deposition in mild cognitive impairment: a PET study.

Authors:  A Okello; P Edison; H A Archer; F E Turkheimer; J Kennedy; R Bullock; Z Walker; A Kennedy; N Fox; M Rossor; D J Brooks
Journal:  Neurology       Date:  2009-01-06       Impact factor: 9.910

Review 10.  NADPH oxidase as a therapeutic target in Alzheimer's disease.

Authors:  Michelle L Block
Journal:  BMC Neurosci       Date:  2008-12-03       Impact factor: 3.288

View more
  27 in total

Review 1.  Molecular and functional properties of P2X receptors--recent progress and persisting challenges.

Authors:  Karina Kaczmarek-Hájek; Eva Lörinczi; Ralf Hausmann; Annette Nicke
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

Review 2.  The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease.

Authors:  Gholamreza Azizi; Shadi S Navabi; Ahmed Al-Shukaili; Mir H Seyedzadeh; Reza Yazdani; Abbas Mirshafiey
Journal:  Sultan Qaboos Univ Med J       Date:  2015-08-24

Review 3.  Purinergic receptors as potential therapeutic targets in Alzheimer's disease.

Authors:  Lucas T Woods; Deepa Ajit; Jean M Camden; Laurie Erb; Gary A Weisman
Journal:  Neuropharmacology       Date:  2015-10-28       Impact factor: 5.250

Review 4.  Neuroinflammation in psychiatric disorders: PET imaging and promising new targets.

Authors:  Jeffrey H Meyer; Simon Cervenka; Min-Jeong Kim; William C Kreisl; Ioline D Henter; Robert B Innis
Journal:  Lancet Psychiatry       Date:  2020-10-21       Impact factor: 27.083

Review 5.  Sleep and immune function: glial contributions and consequences of aging.

Authors:  Ashley M Ingiosi; Mark R Opp; James M Krueger
Journal:  Curr Opin Neurobiol       Date:  2013-02-26       Impact factor: 6.627

6.  Small molecule inducers of ABCA1 and apoE that act through indirect activation of the LXR pathway.

Authors:  Jianjia Fan; Rui Qi Zhao; Cameron Parro; Wenchen Zhao; Hsien-Ya Chou; Jerome Robert; Tarek Z Deeb; Carina Raynoschek; Samantha Barichievy; Ola Engkvist; Marcello Maresca; Ryan Hicks; Johan Meuller; Stephen J Moss; Nicholas J Brandon; Michael W Wood; Iva Kulic; Cheryl L Wellington
Journal:  J Lipid Res       Date:  2018-03-21       Impact factor: 5.922

Review 7.  Glial Purinergic Signaling in Neurodegeneration.

Authors:  Marie J Pietrowski; Amr Ahmed Gabr; Stanislav Kozlov; David Blum; Annett Halle; Kevin Carvalho
Journal:  Front Neurol       Date:  2021-05-14       Impact factor: 4.003

8.  Increased cerebrospinal fluid adenosine 5'-triphosphate in patients with amyotrophic lateral sclerosis.

Authors:  Takamasa Nukui; Atsushi Matsui; Hideki Niimi; Tomoyuki Sugimoto; Tomohiro Hayashi; Nobuhiro Dougu; Hirofumi Konishi; Mamoru Yamamoto; Ryoko Anada; Noriyuki Matsuda; Isao Kitajima; Yuji Nakatsuji
Journal:  BMC Neurol       Date:  2021-06-30       Impact factor: 2.474

9.  Neurotransmitter signaling in the pathophysiology of microglia.

Authors:  María Domercq; Nuria Vázquez-Villoldo; Carlos Matute
Journal:  Front Cell Neurosci       Date:  2013-04-19       Impact factor: 5.505

Review 10.  Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity.

Authors:  Andrew D Kraft; G Jean Harry
Journal:  Int J Environ Res Public Health       Date:  2011-07-20       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.